1. Home
  2. FRMI vs RLAY Comparison

FRMI vs RLAY Comparison

Compare FRMI & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fermi Inc.

FRMI

Fermi Inc.

HOLD

Current Price

$6.29

Market Cap

4.7B

Sector

Real Estate

ML Signal

HOLD

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$19.52

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRMI
RLAY
Founded
2025
2015
Country
United States
United States
Employees
35
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
4.1B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
FRMI
RLAY
Price
$6.29
$19.52
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
10
Target Price
$26.13
$19.50
AVG Volume (30 Days)
18.0M
4.2M
Earning Date
05-13-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
31.78
EPS
N/A
N/A
Revenue
N/A
$15,355,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$120.76
$324.03
P/E Ratio
N/A
N/A
Revenue Growth
N/A
53.44
52 Week Low
$4.47
$3.03
52 Week High
$32.39
$20.79

Technical Indicators

Market Signals
Indicator
FRMI
RLAY
Relative Strength Index (RSI) 38.22 63.14
Support Level $4.79 $12.10
Resistance Level $7.28 N/A
Average True Range (ATR) 0.81 1.31
MACD -0.32 0.14
Stochastic Oscillator 9.50 73.66

Price Performance

Historical Comparison
FRMI
RLAY

About FRMI Fermi Inc.

Fermi Inc building a private power campus for AI-centric customers, developing and leasing large-scale, grid-independent energy generation and high-performance computing facilities purpose-built for the hyperscale era. The company is also developing a private energy and site infrastructure platform across the campus to support multiple powered shell buildings and a diversified, integrated power supply, including private power generation and delivery infrastructure, substations, internal distribution networks, water and cooling systems, and other essential infrastructure. In addition to powered shell facilities, it may offer long-term ground leases to tenants that elect to construct their own powered shell facilities on land, with or without integrated power delivery.

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.

Share on Social Networks: